N/A N=11 Magnetic Resonance Imaging Using Innovative Pulse Sequences
Clinical Indication for a Head MRI
Primary: Number of Head Images Successfully Collected — 10 Images
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=14 MR Fingerprinting: A Novel Sequence Applied to Neuroimaging
Disease;Neurological
Primary: Percent of Participants With Visible Region of Interest (Imaging Visibility) — 100 percentage of participants
N/A N=22 Novel MRI Sequence- MR Fingerprinting
Disease
Primary: Percent of Patients With Visible Region of Interest (Imaging Visibility)
N/A N=43 Magnetic Resonance Imaging Study of Geriatric Depression
Major Depressive Disorder
Primary: HAM-D 17 (Hamilton Depression Rating Scale) — 1.0; 18.5 Units on a scale
N/A N=16 Dynamic Magnetic Resonance Imaging (MRI) for Lung Tumor Motion and Lung Function (GCC 0943)
Lung Cancer
Primary: Number of Participants Whose Tumor Position is Visible Within ~2mm Using Cine-MRI Scans and External Sensors — 7 participants
N/A N=21 Magnetic Resonance Imaging (MRI) of Appendicitis in Children
Appendicitis
Primary: Diagnostic Sensitivity/Specificity and Accuracy of Appendiceal MRI Comparedsurgical Findings or Clinical Follow-up — 13; 17; 4; 19 participants
N/A N=6 Magnetic Resonance Imaging Evaluation of Inner Ear Pathology Using Intra-Tympanic Contrast Agent
Meniere's Disease
Primary: Vestibular "Endolymphatic Hydrops (EH)" — 0; 4; 2 participants
N/A N=57 Magnetic Resonance Imaging (MRI) Brachytherapy Applicator Study
Cervical Cancer
Primary: Number of Participants With Improved Image Quality in the Shifted Position — 0; 15 Participants
N/A N=1,509 Clinically Indicated Magnetic Resonance Imaging in Patients With Cardiac Devices
Arrhythmias, Cardiac
Primary: Device Malfunction — 24; 52 Participants
N/A N=32 Magnetic Resonance Imaging in Subjects With Gouty Tophi
Hyperuricemia · Gout
Primary: Measurement of Tophi by MRI - Difference in Volument Between Visits — -0.05 centimeters³ (cm³) — p=0.785
N/A N=189 Comparative Study of Conventional MR Images With Synthetically Reconstructed MR Images of the Brain
Clinical Indication for Brain MRI · Healthy Volunteers
Primary: Sensitivity of Pathological Findings (Full Analysis Set) — 0.66; 0.68 Proportion of participants
Phase 2 N=119 Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD)
Peripheral Arterial Disease (PAD)
Primary: Segment-level Sensitivity and Specificity of VE-MRI at 3 Ferumoxytol Dosing Levels and Differences in Sensitivity and Specificity by Dose Group — 71.8; 76.8; 81.8; 71.2…
N/A N=38 An Investigational Scan (7T MRI) for the Imaging of Central Nervous System Tumors
Central Nervous System Neoplasm · Glioma · Metastatic Malignant Neoplasm in the Central Nervous System
Primary: Contrast-to-noise Ratio (CNR) — 60.6; 58.4 contrast-to-noise ratio
N/A N=239 ENABLE MRI (Magnetic Resonance Imaging)
Magnetic Resonance Imaging
Primary: Percentage of Participants Free From MR (Magnetic Resonance) Scan-related Complications — 100 percentage of participants
N/A N=117 Comparative Study of Conventional 1.5 and 3.0T MR Images With Synthetically Reconstructed MR Images
Clinical Indication for Brain MRI
Primary: Mean Diagnostic Image Quality Difference Between Conventional Versus Synthetic MR Utilizing a 5 Point Likert Scale — -0.335 units on a 5-point scale — p=<0.001
N/A N=14 Role of Magnetic Resonance Fingerprinting and Quantitative MR Imaging in Breast Cancer
Breast Cancer
Primary: Utility of Percentage Change in Longitudinal (T1) and Transverse (T2) Relaxation Times From Baseline to First Cycle of Treatment in Assessment of Response to…
N/A N=208 MRI Based Active Selection for Treatment Trial
Prostate Cancer
Primary: Rate of Disease Progression Within the First Two Surveillance Biopsies — 36.1 percentage of participants
Phase 4 N=276 Detection of Liver Fibrosis With Magnetic Resonance Imaging (MRI)
Chronic Liver Disease
Primary: PV Flow — 16.0; 15.5; 23.2; 27.1 ml/s
N/A N=4 Magnetic Resonance Imaging (MRI) to Assess Radial Artery Compression and Arterial Perfusion While TR Band is Applied
Poor Peripheral Perfusion
Primary: MRI Based Radial Artery Measurement — 1.35 millimeters
N/A N=1,007 Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
Breast Cancer · Contralateral Breast Cancer
Primary: MRI Diagnostic Yield of Cancers in the Contralateral Breast — 30; 114; 3; 822 Participants
Phase 2 N=40 Positron Emission Tomography and Magnetic Resonance Imaging for Prostate Cancer
Prostate Cancer
Primary: Compare the Biodistribution of 11C-acetate Positron Emission Tomography (PET)/Computed Tomography (CT) Imaging in Tumor and Non Tumorous Regions of the Prostate — 4.4…
Phase 2 N=44 Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease
Liver Cancer
Primary: Overall Image Quality of Magnetic Resonance Elastography (MRE)
N/A N=57 Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy
Breast Cancer
Primary: Correlation Between Prone Breast MRI for Estimation of Tumor Size and Final Pathology Tumor Size — 0.635 correlation coefficient
N/A N=84 Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI)
Hepatocellular Carcinoma · HCC
Primary: SubStudy 1: Apparent Diffusion Coefficient (ADC) — 1.43 1x10^-3 mm^2/s
N/A N=15 Advanced MRI Scan Before and After Radiation Therapy for the Detection of Intracranial Metastasis
Malignant Solid Neoplasm
Primary: Contrast to Noise Ratio — 3.2 Ratio — p=< 0.05
N/A N=26 Sensory Effects of Rapidly-Changing Magnetic Fields
Sensory Disorders
Primary: Degree of Discomfort Under Applied Pulsed Magnetic Fields — 0 percentage of subjects with discomfort
N/A N=31 Improved Breast MRI With SWIFT
Breast Cancer
Primary: Lesions — 0; 12 lesions
N/A N=29 3D MR Versus 3D CT for Glenohumeral Arthritis
Arthritis · Glenohumeral Osteoarthritis
Primary: Glenoid Version — 12.1; 11.4 degrees
N/A N=477 Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2
Concussion · Traumatic Brain Injury
Primary: MRI Image Data Sets — 79; 150; 290; 111 Images collected
Phase 4 N=20 Stress Testing and Cardiac Magnetic Resonance
Coronary Disease
Primary: Major Adverse Cardiovascular Events — 0 Participants